| Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
|
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
4.21E-01
|
-1.27E-02
|
-5.11E-02 |
|
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
8.75E-03
|
1.04E-01
|
3.57E-01 |
|
Asthma
|
CA23 |
Nasal and bronchial airway |
7.95E-01
|
6.31E-03
|
7.57E-03 |
|
Behcet's disease
|
4A62 |
Peripheral blood |
8.08E-01
|
-2.05E-02
|
-8.24E-02 |
|
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
6.06E-01
|
1.05E-03
|
4.24E-03 |
|
Bladder cancer
|
2C94 |
Bladder tissue |
8.58E-11
|
7.59E-01
|
6.95E+00 |
|
Breast cancer
|
2C60-2C6Z |
Breast tissue |
5.63E-30
|
-4.59E-01
|
-1.07E+00 |
|
Colon cancer
|
2B90 |
Colon tissue |
1.07E-73
|
-1.20E+00
|
-2.64E+00 |
|
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
4.82E-01
|
-6.06E-02
|
-1.35E-01 |
|
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
1.54E-01
|
-1.26E-01
|
-6.21E-01 |
|
Gastric cancer
|
2B72 |
Gastric tissue |
1.26E-01
|
-8.60E-01
|
-1.59E+00 |
|
Glioblastopma
|
2A00.00 |
Nervous tissue |
5.21E-14
|
3.53E-01
|
5.48E-01 |
|
Head and neck cancer
|
2D42 |
Head and neck tissue |
2.56E-11
|
-5.42E-01
|
-6.69E-01 |
|
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
5.49E-01
|
-1.61E-02
|
-4.12E-02 |
|
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
2.99E-02
|
3.99E-01
|
1.20E+00 |
|
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
2.94E-02
|
-1.32E-01
|
-1.71E+00 |
|
Ischemic stroke
|
8B11 |
Peripheral blood |
4.11E-02
|
6.64E-02
|
4.29E-01 |
|
Liver cancer
|
2C12.0 |
Liver tissue |
3.61E-08
|
-8.77E-01
|
-1.28E+00 |
|
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
1.27E-05
|
-1.02E+00
|
-2.60E+00 |
|
Lung cancer
|
2C25 |
Lung tissue |
4.80E-02
|
-9.64E-02
|
-2.85E-01 |
|
Lupus erythematosus
|
4A40 |
Whole blood |
7.57E-01
|
6.83E-02
|
1.69E-01 |
|
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
4.94E-01
|
-2.33E-02
|
-9.31E-02 |
|
Multiple myeloma
|
2A83.1 |
Bone marrow |
1.35E-05
|
-1.04E+00
|
-3.65E+00 |
|
Multiple myeloma
|
2A83.1 |
Peripheral blood |
1.26E-01
|
2.91E-01
|
1.29E+00 |
|
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
7.51E-02
|
-2.59E-01
|
-1.43E+00 |
|
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
9.26E-03
|
2.59E-01
|
6.63E-01 |
|
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
1.50E-01
|
-1.30E-01
|
-1.70E-01 |
|
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
1.78E-09
|
-1.74E+00
|
-5.27E+00 |
|
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
4.31E-04
|
-5.64E-01
|
-2.42E+00 |
|
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
6.35E-01
|
1.21E-01
|
1.92E-01 |
|
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
3.98E-01
|
2.04E-01
|
4.76E-01 |
|
Oral cancer
|
2B6E |
Oral tissue |
3.33E-02
|
2.55E-03
|
4.07E-03 |
|
Ovarian cancer
|
2C73 |
Ovarian tissue |
6.78E-02
|
5.53E-02
|
2.50E-01 |
|
Pancreatic cancer
|
2C10 |
Pancreas |
4.85E-01
|
-6.35E-02
|
-1.74E-01 |
|
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
5.26E-01
|
7.09E-02
|
2.12E-01 |
|
Pituitary cancer
|
2D12 |
Pituitary tissue |
1.38E-04
|
-8.23E-01
|
-1.81E+00 |
|
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
6.69E-01
|
2.53E-02
|
7.30E-02 |
|
Pompe disease
|
5C51.3 |
Biceps muscle |
1.17E-01
|
2.25E-01
|
1.13E+00 |
|
Prostate cancer
|
2C82 |
Prostate |
1.95E-09
|
-6.84E-01
|
-1.57E+00 |
|
Psoriasis
|
EA90 |
Skin |
2.68E-02
|
-1.64E-01
|
-4.69E-01 |
|
Rectal cancer
|
2B92 |
Rectal colon tissue |
4.43E-05
|
-9.56E-01
|
-3.87E+00 |
|
Renal cancer
|
2C90-2C91 |
Kidney |
3.45E-03
|
-7.44E-01
|
-7.66E-01 |
|
Retinoblastoma
|
2D02.2 |
Uvea |
3.02E-05
|
1.29E+00
|
5.35E+00 |
|
Schizophrenia
|
6A20 |
Prefrontal cortex |
1.99E-01
|
3.50E-01
|
5.52E-01 |
|
Schizophrenia
|
6A20 |
Superior temporal cortex |
4.31E-01
|
-6.82E-02
|
-3.06E-01 |
|
Scleroderma
|
4A42.Z |
Whole blood |
9.24E-02
|
-1.40E-01
|
-6.36E-01 |
|
Seizure
|
8A60-8A6Z |
Whole blood |
5.22E-01
|
1.03E-01
|
3.62E-01 |
|
Sepsis with septic shock
|
1G41 |
Whole blood |
1.40E-06
|
-1.24E-01
|
-4.78E-01 |
|
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
6.29E-01
|
1.11E-01
|
7.83E-01 |
|
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
5.91E-01
|
-4.10E-01
|
-6.16E-01 |
|
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
2.66E-03
|
4.59E-01
|
3.05E+00 |
|
Skin cancer
|
2C30-2C3Z |
Skin |
1.99E-03
|
3.74E-01
|
7.66E-01 |
|
Thrombocythemia
|
3B63 |
Whole blood |
2.09E-05
|
1.39E-01
|
1.26E+00 |
|
Thrombocytopenia
|
3B64 |
Whole blood |
2.61E-01
|
-1.39E-01
|
-2.13E-01 |
|
Thyroid cancer
|
2D10 |
Thyroid |
9.22E-19
|
-4.28E-01
|
-1.42E+00 |
|
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
3.52E-10
|
7.45E-01
|
3.75E+00 |
|
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
1.84E-02
|
6.51E-01
|
3.78E+00 |
|
Type 2 diabetes
|
5A11 |
Liver tissue |
6.16E-01
|
-3.78E-01
|
-9.37E-01 |
|
Ureter cancer
|
2C92 |
Urothelium |
6.92E-02
|
-1.23E-01
|
-5.16E-01 |
|
Uterine cancer
|
2C78 |
Endometrium tissue |
5.68E-03
|
3.14E-01
|
5.19E-01 |
|
Vitiligo
|
ED63.0 |
Skin |
8.97E-02
|
-1.69E-01
|
-3.30E-01 |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
